tirzepatide cancelled Compounding pharmacies can resume making as FDA reconsiders shortage Zepbound copycats remain online despite

Jastreboff, M.D., Ph.D., Louis J

In contrast, Wegovy, containing the same active ingredient semaglutide, was developed specifically for weight loss and is approved solely for that purpose

It offers a good balance between manageable injection volumes and the ability to cover the full tirzepatide dosing range without needing extremely small or extremely large draws

2025, 13(3), 221 62, doi: 10.1016/S2213-8587(24)00316-4

Mislabeled vials are a common source of dosing errors

Some critics called the decision short-sighted, arguing that treating obesity now prevents far more expensive conditions later, things like heart disease, stroke, kidney failure, and certain cancers